BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38613789)

  • 1. Diagnostic accuracy of International System for Reporting Serous Fluid Cytopathology: A systematic review and meta-analysis in malignancy diagnosis.
    Ahuja S; Ahuja R; Pandey S; Zaheer S
    Cancer Cytopathol; 2024 Apr; ():. PubMed ID: 38613789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Retrospective Analysis of the Application of the Newly Proposed International System for Reporting Serous Fluid Cytopathology on Serous Effusion Specimens: An Institutional Experience.
    Rajeswaran PK; Srinivasan V; Mahesh SSV; Ashok AU
    Acta Cytol; 2023; 67(1):70-79. PubMed ID: 36476509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Categorisation of serous effusions using the International System for Reporting Serous Fluid Cytopathology and assessment of risk of malignancy with diagnostic accuracy.
    Ahuja S; Malviya A
    Cytopathology; 2022 Mar; 33(2):176-184. PubMed ID: 34913541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering Serous Effusions Using the New International System for Reporting Serous Fluid Cytopathology.
    Mandava H; Venkata Renuka I; Potti R; Mounica B; Kalla I
    Cureus; 2024 May; 16(5):e60042. PubMed ID: 38774462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Review and Meta-Analysis of the Diagnostic Accuracy of the Sydney System for Reporting Lymph Node Fine-Needle Aspiration Biopsy in Diagnosing Malignancy.
    Ahuja S; Aziz Khan A; Ahuja R; Ahuja P; Zaheer S
    Acta Cytol; 2024; 68(1):13-25. PubMed ID: 38096796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
    Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
    Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on Reporting Pericardial Effusion Cytology.
    Rodriguez EF; Jones R; Gabrielson M; Santos D; Pastorello RG; Maleki Z
    Acta Cytol; 2020; 64(5):477-485. PubMed ID: 32422631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of international system for reporting serous fluid cytology (ISRSFC) in effusion samples-a prospective study in an oncology setting.
    Sachan R; Gupta A; Awasthi PN; Singh P; Anand N; Chandra S; Gaur G; Husain N; Sachan KD
    J Am Soc Cytopathol; 2023; 12(5):351-361. PubMed ID: 37244848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk.
    Wang M; Sun T; Jiao J; Wang H
    Cancer Cytopathol; 2023 Jul; 131(7):433-441. PubMed ID: 36973963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) in reporting serous effusion: A retrospective study.
    Yang H; Zhu J; Wang P
    Medicine (Baltimore); 2023 Oct; 102(43):e35707. PubMed ID: 37904355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the international system for reporting serous fluid cytopathology on reporting various body fluids; experience of a tertiary care hospital.
    Kolte S; Zaheer S; Aden D; Ranga S
    Cytojournal; 2022; 19():52. PubMed ID: 36128470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective analysis of serous effusions based on the newly proposed international system for reporting serous fluid cytopathology: a report of 3633 cases in an oncological center.
    Zhu YL; Ren WH; Wang Q; Jin HZ; Guo YY; Lin DM
    Diagn Pathol; 2022 Jul; 17(1):56. PubMed ID: 35780135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The International System for Reporting Serous Fluid Cytopathology: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies.
    Jamal FE; Vey JA; Proctor T; Ishak A; Schmitt FC; Nikas IP
    Adv Anat Pathol; 2024 Jul; 31(4):256-264. PubMed ID: 38695284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the International System for Reporting Serous Fluid Cytopathology (TIS): A retrospective institutional study.
    Straccia P; Chiappetta M; Magnini D; Cancellieri A
    Cytopathology; 2022 May; 33(3):305-311. PubMed ID: 35213747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Review and Meta-Analysis of the Diagnostic Accuracy of the International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy in Diagnosing Breast Cancer.
    Paul P; Azad S; Agrawal S; Rao S; Chowdhury N
    Acta Cytol; 2023; 67(1):1-16. PubMed ID: 36412573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Novel Tiered Reporting System in Serous Fluid Cytology and Risk of Malignancy Assessment: A Retrospective Study in a Tertiary Care Center.
    Alashetty S; Sadasivan B; Dharmalingam P; Rajagopal N; Kavya L; Pai MM
    J Cytol; 2023; 40(3):107-113. PubMed ID: 37745807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Categorisation of peritoneal serous effusions using the International System for Reporting Serous Fluid Cytopathology-A study on gynaecological samples.
    Rakheja G; Singh M; Priyadarshnee B; Marimuthu B; Dhar L; Jain S; Khurana N; Rathore A
    Cytopathology; 2023 Mar; 34(2):138-145. PubMed ID: 36530023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of malignancy assessment of the International System for Reporting Serous Fluid Cytopathology: Experience in a community hospital setting and comparison with other studies.
    Sun T; Wang M; Wang H
    Cancer Cytopathol; 2022 Dec; 130(12):964-973. PubMed ID: 35994357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the newly published International System for Reporting Serous Fluid Cytopathology in atypical and suspicious diagnosis: a four-year retrospective analysis.
    Shen Y; Gosnell JM; Nawgiri R; Muthukumarana V
    J Am Soc Cytopathol; 2024 Mar; ():. PubMed ID: 38637263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the International System for Reporting Serous Fluid Cytopathology: A multi-institutional study in Taiwan.
    Lu CH; Liu CY; Jhuang JY; Chen CC
    Cancer Cytopathol; 2024 Mar; 132(3):169-178. PubMed ID: 38062987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.